Applications of Two-Dimensional Electrophoresis Technology to the Study of Atherosclerosis.
Atherosclerosis is a multifactorial disease in which hypertension, diabetes, hyperlipidemia and other risk factors are thought to play a role. However, the molecular processes underlying plaque formation and progression are not yet completely known. In the last years some researchers applied proteomics technologies for the comprehension of biochemical pathways of atherogenesis and to search new cardiovascular biomarkers to be utilized either as early diagnostic traits or as targets for new drug therapies. Due to its intrinsic complexity, the problem has been approached by different strategies, all of which have some limitations. In this review, we summarize the most common critical experimental variables in two-dimensional electrophoresis-based techniques and recent data obtained by applying proteomic approaches in the study of atherosclerosis.
Department of Physiological, Biochemical and Cellular Sciences, University of Sassari , Italy.
Antonio J
AJ
Lepedda
Department of Physiological, Biochemical and Cellular Sciences, University of Sassari , Italy.
Marilena
M
Formato
Proteomics. 2003 Jun;3(6):973-8
12833522
Arterioscler Thromb Vasc Biol. 2003 Dec;23(12):2123-30
14512372
Proteomics. 2006 Jan;6(2):721-30
16419016
Arterioscler Thromb Vasc Biol. 2000 May;20(5):1262-75
10807742
Cell Struct Funct. 2003 Dec;28(6):495-503
15004419
Arterioscler Thromb Vasc Biol. 1995 May;15(5):551-61
7749869
J Pathol. 2005 May;206(1):39-45
15772986
Biomarkers. 2006 May-Jun;11(3):279-90
16760137
Proteomics. 2004 Jun;4(6):1761-78
15174143
Atherosclerosis. 2009 Mar;203(1):112-8
18715566
Proteomics. 2007 Jan;7(1):143-54
17154273
Proteomics. 2005 Feb;5(2):551-65
15627967
Mol Cell Proteomics. 2004 Feb;3(2):115-24
14612593
Proteomics. 2006 Feb;6(4):1261-73
16402358
Circulation. 2004 Oct 12;110(15):2216-9
15249501
Mol Cell Proteomics. 2004 Dec;3(12):1200-10
15496433
Proteomics. 2005 Aug;5(13):3520-30
16052623
Proteomics. 2003 Sep;3(9):1767-80
12973737
Nature. 2002 Dec 19-26;420(6917):868-74
12490960
Proteomics. 2005 Apr;5(5):1431-45
15761960
Eur J Pharmacol. 2007 May 7;562(1-2):119-29
17336287
J Biol Chem. 1975 May 25;250(10):4007-21
236308
Circ Res. 2004 May 28;94(10):e87-96
15131007
Proteomics. 2004 Nov;4(11):3383-93
15378733
Proteomics. 2005 Feb;5(2):585-96
15627955
Proteomics. 2003 May;3(5):714-23
12748950
Physiol Genomics. 2003 Mar 18;13(1):25-30
12644631
Arterioscler Thromb Vasc Biol. 2000 May;20(5):1177-8
10807728
J Biol Chem. 2003 Aug 1;278(31):29136-44
12754261